Novartis Pharmaceuticals Corporation

NJ · United States · Reporting entity ID 100000000228

Total reported 2019–2025

$3.55B

#4 of 2,960 reporting companies — 4.3% of all reported industry payments

$144.5M in general payments across 2,338,963 records, plus $3.41B in research funding across 50,689 records.

How it breaks down

General payments $144,466,766

Research funding $3,405,749,898

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.